GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CXW · Dec 31, 2018

CoreCivic, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001564590-19-004033Reit
Operating-cash-flow growth44thOwn-history percentile · N=18
Evidence method

Yoy · gp.fundamentals.operating_cash_flow

-5.40% · OPTIONAL · VALID

Debt100thOwn-history percentile · N=16
Evidence method

Level · gp.fundamentals.gross_debt

$1.8B · CORE · VALID

Net-income growth50thOwn-history percentile · N=18
Evidence method

Yoy · gp.fundamentals.net_income

-10.58% · CORE · VALID

Cash and equivalents50thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$52.8M · CORE · VALID

Operating-income growth44thOwn-history percentile · N=18
Evidence method

Yoy · gp.fundamentals.operating_income

-4.19% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History49 statesSelf-history eligible
Period transition

What moved in the state?

Cash Generation Decreased
Previous
24.05%
Current
-5.40%
Delta
-29.46%
Debt Increased
Previous
$1.8B
Current
$1.8B
Delta
$36.7M
Earnings Growth Decreased
Previous
-0.45%
Current
-10.58%
Delta
-10.13%
Liquidity Decreased
Previous
$93.6M
Current
$52.8M
Delta
-$40.8M
Profitability Decreased
Previous
5.93%
Current
-4.19%
Delta
-10.12%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.